Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California
blank

 

Recent News and Articles on the Keywords: lymphoma drug + skin disorders + lymphoma  Related to the article below (Last Update: 5/13/2008)

Amgen to Participate in Dermatologic and Ophthalmic Drugs Advisory ...
WELT ONLINE, Germany - May 1, 2008
There have been rare reports of serious blood disorders (some fatal). In medical studies, more cases of lymphoma (a type of cancer) were seen in patients ...AMGN
In marijuana debate, both sides can point to the science
Minneapolis Star Tribune, MN - Apr 20, 2008
Still, the growing body of research has won over some major medical groups, such as the Leukemia and Lymphoma Society, and the American College of ...
Therakos, Inc. Receives CE Mark in Europe For Next-Generation ...
PR Newswire UK (press release), UK - Apr 14, 2008
The white blood cells are treated with methoxsalen, a drug used to treat some cutaneous lymphomas and skin disorders in conjunction with exposure to ...
Rigel's R788 Slows Progression of Murine Lupus in Preclinical Studies
CNNMoney.com (press release) - Apr 29, 2008
A third clinical trial of R788 in patients with B-cell lymphoma will be completed later this year. Rigel also expects to initiate a Phase 2 clinical trial ...RIGL
Abbott Announces HUMIRA(R) (adalimumab) Approved in Japan for the ...
CNNMoney.com (press release) - Apr 16, 2008
More cases of malignancies including lymphoma have been observed among patients receiving a TNF antagonist compared with control patients in clinical trials ...ABT
Rigel's R788 Slows Progression of Murine Lupus in Preclinical Studies
Earthtimes (press release), UK - Apr 29, 2008
A third clinical trial of R788 in patients with B-cell lymphoma will be completed later this year. Rigel also expects to initiate a Phase 2 clinical trial ...RIGL

In order to show you the most relevant results, we have omitted some entries very similar to the 6 already displayed.
If you like, you can repeat the search with the omitted results included.

Source: Google News

Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment.
LJ Kinlen - Am J Med, 1985 - ncbi.nlm.nih.gov
... without transplants treated with immunosuppressive drugs (68 percent ... an excess of
non-Hodgkin's lymphoma and squamous cell skin cancer, suggesting ...

… Safe for Treatment of Refractory Advanced-Stage Cutaneous T-Cell Lymphoma: Multinational Phase II- … -
M Duvic, K Hymes, P Heald, D Breneman, AG Martin, … - Journal of Clinical Oncology, 2001 - jcojournal.org
... six of 56), pruritus (7.1%), rash (3.6%), and skin disorder (3.6 ... approved by the
United States Food and Drug Administration for cutaneous T-cell lymphoma. ...

… factor antagonist therapy and lymphoma development: Twenty-six cases reported to the Food and Drug … -
SL Brown, MH Greene, SK Gershon, ET Edwards, MM … - Arthritis & Rheumatism, 2002 - Mass Med Soc
... by the Food and Drug Administration (FDA ... authors describe cases of lymphoproliferative
disorders associated with ... respectively, involved non-Hodgkin lymphoma (NHL ...

Primary Cutaneous T-Cell Lymphoma: Review and Current Concepts -
RS Siegel, T Pandolfino, J Guitart, S Rosen, TM … - Journal of Clinical Oncology, 2000 - jco.ascopubs.org
... common toxicity is drying of the skin and mucous ... IL-2 is now Federal Drug
Administration?approved ... CD30+ Primary Cutaneous Large-Cell Lymphoma Patients with ...

… and 2 Trial of Bexarotene Gel for Skin-Directed Treatment of Patients With Cutaneous T-Cell Lymphoma -
D Breneman, M Duvic, T Kuzel, R Yocum, J Truglia, … - Archives of Dermatology, 2002 - Am Med Assoc
... 3. Cutaneous T-cell lymphoma is characterized by the accumulation of a clonal ... MF
because it allowed a high concentration of drug at lesional skin sites while ...

Skin Cancers and Non-Hodgkin Lymphoma Among Users of Systemic Glucocorticoids: A Population-Based … -
HT Sorensen, L Mellemkjaer, GL Nielsen, JA Baron, … - jnci, 2004 - jnci.oxfordjournals.org
... for non-Hodgkin lymphoma and skin cancers, primarily ... with more commonly used
immunosuppressive drugs such as ... of melanomas or non-Hodgkin lymphoma in relation ...

Post-Transplant Malignancy: The Role Of Immunosuppression. -
I Penn - Drug Safety, 2000 - drugsafety.adisonline.com
... The risk of skin cancer in renal transplant ... Principles of drug development in
transplantation and autoimmunity. ... role of immunosuppression in lymphoma formation ...

2-Chlorodeoxyadenosine: an active agent in the treatment of cutaneous T-cell lymphoma. -
A Saven, CJ Carrera, DA Carson, E Beutler, LD Piro - Blood, 1992 - ncbi.nlm.nih.gov
... Cutaneous T-cell lymphomas are disfiguring malignant lymphoproliferative disorders
for which ... to 16 patients with cutaneous involvement by T-cell lymphoma. ...

Current use and future potential role of retinoids in dermatology. -
CE Orfanos, CC Zouboulis, B Almond-Roesler, CC … - Drugs, 1997 - ncbi.nlm.nih.gov
Drugs. ... chemoprevention of epithelial skin cancer and cutaneous T cell lymphoma. ...
application includes acne, aging, photodamage, precanceroses, skin cancer and ...

Prior Medical Conditions and Medication use and Risk of non-Hodgkin lymphoma in Connecticut United … -
Y Zhang, TR Holford, B Leaderer, SH Zahm, P Boyle, … - Cancer Causes and Control, 2004 - Springer
... Use of steroidal anti- inflammatory drugs and tranquilizers ... and psoriasis, two chronic
skin conditions, were ... association between T-cell lymphoma and eczema [35 ...

Source: Google Scholar

Skin Disorders Treated With Lymphoma Drug
A new review article from the journal Dermatologic Therapy reveals that rituximab, a drug used to treat lymphoma, is now becoming used by dermatologists to treat various dangerous skin diseases.

Originally developed as the standard therapy in treating aggressive lymphomas, the drug rituximab is showing increased non-cancer use. The study reviewed the off-label uses of rituximab in dermatology and found that it successfully treated patients with various kinds of blistering skin disease, including pemphigus vulgaris, dermatomyositis, and paraneoplastic pemphigus.

Newer, safer treatments are being studied for serious dermatologic disorders, and rituximab's efficacy has been shown in a variety of dangerous skin problems. "As case reports and randomized trials explore the utility of rituximab," the authors note, "the indications for rituximab will continue to be defined."


This study is published in the journal Dermatologic Therapy.

To view the abstract for this article, please click here.

Michael P. Heffernan, MD, is affiliated with Wright State University in Dayton, Ohio.

Dermatologic Therapy was created to fill an important void in the dermatologic literature: the lack of a readily available source of up-to-date information on the treatment of specific cutaneous diseases and the practical application of specific treatment modalities. The information contained in each issue is so practical and detailed that the reader should be able to directly apply various treatment approaches to daily clinical situations.

Wiley-Blackwell was formed in February 2007 as a result of the acquisition of Blackwell Publishing Ltd. by John Wiley & Sons, Inc., and its merger with Wiley's Scientific, Technical, and Medical business. Together, the companies have created a global publishing business with deep strength in every major academic and professional field. Wiley-Blackwell publishes approximately 1,400 scholarly peer-reviewed journals and an extensive collection of books with global appeal. For more information on Wiley-Blackwell, please visit http://www.blackwellpublishing.com/ or http://interscience.wiley.com/ .

Source: Amy Molnar
Blackwell Publishing Ltd.
 
 
 
Google
Web www.iconocast.com

Search inside Iconocast for the keyword you have in mind.

Iconocast has collected more than 50,000 articles and press releases on health and science.

These are current and most up to date press releases on the subject you are searching.

We collect current health and science press releases daily from more than 5000 research and health institutes. Here is an example : The elderberry way to perfect skin

We believe if you do search inside Iconocast, you will get better results than searching the web alone.

 
 
Continue News With: News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services.

 

Iconocast Home Page

Contact Iconocast

© 2003-07. ICONOCAST is a trademark of iconocast.com.